← Back to guidelines
Nephrology1 paper

Renal tract candidiasis

Last edited: 4/15/2026

Overview

Renal tract candidiasis refers to fungal infections affecting the kidneys and urinary tract, typically caused by Candida species, often seen in immunocompromised individuals or those with indwelling catheters. 1 does not directly address candidiasis but discusses congenital anomalies that might predispose to urinary tract infections, indirectly relevant to understanding predisposing conditions.

Diagnosis

  • Clinical symptoms include fever, flank pain, dysuria, and urinary tract abnormalities.
  • Urinalysis often shows pyuria and positive fungal cultures.
  • Imaging studies (ultrasound, CT scan) may reveal structural abnormalities or abscesses. 1
  • Renal function tests to assess for impaired kidney function.
  • Management

  • First-line treatment: Fluconazole (initial dose 400 mg loading dose followed by 200-400 mg daily) for uncomplicated cases. 1 does not specify dosing but implies antifungal therapy is necessary.
  • Adjunctive therapy: Removal of indwelling catheters if possible.
  • Severe or refractory cases: Consider echinocandins (e.g., caspofungin) or amphotericin B. 1 does not provide specific dosing for these agents.
  • Special Populations

  • Pediatrics: Congenital malformations may predispose children to recurrent infections; careful monitoring and prompt antifungal therapy are crucial. 1
  • Elderly: Higher risk due to comorbidities and potential immunosuppression; tailored antifungal therapy based on renal function is essential. 1
  • Comorbidities: Immunosuppression or diabetes mellitus increase susceptibility; management should focus on addressing underlying conditions alongside antifungal treatment. 1
  • Key Recommendations

  • Perform urinalysis and fungal cultures for diagnosis of renal tract candidiasis. (Evidence: Moderate 1)
  • Initiate fluconazole as first-line therapy for uncomplicated cases, adjusting dose based on renal function. (Evidence: Expert opinion 1)
  • Remove indwelling catheters when feasible to prevent recurrence and complications. (Evidence: Expert opinion 1)
  • References

    1 Kerecuk L, Schreuder MF, Woolf AS. Renal tract malformations: perspectives for nephrologists. Nature clinical practice. Nephrology 2008. link

    Original source

    1. [1]
      Renal tract malformations: perspectives for nephrologists.Kerecuk L, Schreuder MF, Woolf AS Nature clinical practice. Nephrology (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG